agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
0.652
-0.076 (-10.41%)
At close: Dec 5, 2025, 4:00 PM EST
0.664
+0.012 (1.82%)
After-hours: Dec 5, 2025, 7:13 PM EST
agilon health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for agilon health stock have an average target of 2.79, with a low estimate of 1.00 and a high estimate of 7.50. The average target predicts an increase of 327.78% from the current stock price of 0.65.
Analyst Consensus: Hold
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
The average analyst rating for agilon health stock from 17 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 13 | 15 | 15 | 15 | 15 | 12 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 21 | 21 | 20 | 20 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $1.5 → $1 | Sell | Maintains | $1.5 → $1 | +53.33% | Nov 6, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $1.5 → $1 | Buy | Maintains | $1.5 → $1 | +53.33% | Nov 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $5 → $1.5 | Buy | Maintains | $5 → $1.5 | +129.99% | Oct 7, 2025 |
| Bernstein | Bernstein | Buy → Hold Downgrades $4 → $1.4 | Buy → Hold | Downgrades | $4 → $1.4 | +114.66% | Aug 20, 2025 |
| Jefferies | Jefferies | Hold Maintains $2.4 → $1.1 | Hold | Maintains | $2.4 → $1.1 | +68.66% | Aug 15, 2025 |
Financial Forecast
Revenue This Year
5.88B
from 6.06B
Decreased by -3.00%
Revenue Next Year
6.08B
from 5.88B
Increased by 3.40%
EPS This Year
-0.77
from -0.63
EPS Next Year
-0.42
from -0.77
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 6.2B | 6.7B | ||||
| Avg | 5.9B | 6.1B | ||||
| Low | 5.7B | 5.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.3% | 14.5% | ||||
| Avg | -3.0% | 3.4% | ||||
| Low | -6.6% | -8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.59 | -0.35 | ||
| Avg | -0.77 | -0.42 | ||
| Low | -0.85 | -0.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.